STOCK TITAN

Avalyn Pharma director proposes $6.25M share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Avalyn Pharma Inc. (AVLN) director and officer Lyn Baranowski gave notice of a proposed sale of 210,000 common shares, with an aggregate market value of $6,249,600 and an approximate sale date of November 17, 2026.

Common shares proposed for sale 210,000 shares Approximate sale date: November 17, 2026
Aggregate market value $6,249,600 Value listed for the proposed sale
Common shares outstanding 44,521,494 shares Number listed in the notice
stock options financial
"received upon exercise of stock options over the next three months"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
Rule 10b5-1 regulatory
"relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AVLN shares is Lyn Baranowski proposing to sell?

Lyn Baranowski's notice lists a proposed sale of 210,000 common shares, with an aggregate market value of $6,249,600 and an approximate sale date of November 17, 2026.

How will Lyn Baranowski acquire the AVLN shares?

The notice states the securities were and will be received upon exercise of stock options over the next three months; acquisition and payment dates were and will be the dates of exercise and sale. It lists a Rule 10b5-1 plan adoption date of July 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading